Treatment (tx) characteristics of patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC) receiving atezolizumab (atezo) monotherapy in US clinical practice Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Frueh, M
  • Rahma, OE
  • Pachynski, RK
  • Mazieres, J
  • Goldschmidt, J
  • Ton, TGN
  • Mhatre, SK
  • Chuo, C-Y
  • Martinalbo, J
  • Davies, J
  • Juergens, Rosalyn

publication date

  • April 2019